{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T14:00:17Z","timestamp":1781791217293,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Comorbid cardiovascular and metabolic risk factors (CVM) differentially impact brain structure and increase dementia risk, but their specific magnetic resonance imaging signatures (MRI) remain poorly characterized. To address this, we developed and validated machine learning models to quantify the distinct spatial patterns of atrophy and white matter hyperintensities related to hypertension, hyperlipidemia, smoking, obesity, and type-2 diabetes mellitus at the patient level. Using harmonized MRI data from 37,096 participants (45\u201385 years) in a large multinational dataset of 10 cohort studies, we generated five in silico severity markers that: i) outperformed conventional structural MRI markers with a ten-fold increase in effect sizes, ii) captured subtle patterns at sub-clinical CVM stages, iii) were most sensitive in mid-life (45\u201364 years), iv) were associated with brain beta-amyloid status, and v) showed stronger associations with cognitive performance than diagnostic CVM status. Integrating personalized measurements of CVM-specific brain signatures into phenotypic frameworks could guide early risk detection and stratification in clinical studies.<\/jats:p>","DOI":"10.1038\/s41467-025-57867-7","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T18:06:35Z","timestamp":1742407595000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Machine learning reveals distinct neuroanatomical signatures of cardiovascular and metabolic diseases in cognitively unimpaired individuals"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1741-0906","authenticated-orcid":false,"given":"Sindhuja Tirumalai","family":"Govindarajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8581-4887","authenticated-orcid":false,"given":"Elizabeth","family":"Mamourian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6633-4861","authenticated-orcid":false,"given":"Guray","family":"Erus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Abdulkadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randa","family":"Melhem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimit","family":"Doshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Pomponio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8644-7724","authenticated-orcid":false,"given":"Duygu","family":"Tosun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5042-7422","authenticated-orcid":false,"given":"Murat","family":"Bilgel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0795-8820","authenticated-orcid":false,"given":"Aristeidis","family":"Sotiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6752-8518","authenticated-orcid":false,"given":"Pamela","family":"LaMontagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8114-0552","authenticated-orcid":false,"given":"Tammie L. S.","family":"Benzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Espeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin L.","family":"Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Maruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3238-7612","authenticated-orcid":false,"given":"Lenore J.","family":"Launer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen","family":"Fripp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8501-545X","authenticated-orcid":false,"given":"Sterling C.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn S.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Nick","family":"Bryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1115-7145","authenticated-orcid":false,"given":"Susan M.","family":"Resnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9447-5805","authenticated-orcid":false,"given":"Mohamad","family":"Habes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3043-047X","authenticated-orcid":false,"given":"Haochang","family":"Shou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Wolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2346-7562","authenticated-orcid":false,"given":"Ilya M.","family":"Nasrallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1025-8561","authenticated-orcid":false,"given":"Christos","family":"Davatzikos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"key":"57867_CR1","first-page":"100256","volume":"11","author":"WV Borelli","year":"2022","unstructured":"Borelli, W. V. et al. Preventable risk factors of dementia: population attributable fractions in a Brazilian population-based study. Lancet Reg. Health Am. 11, 100256 (2022).","journal-title":"Lancet Reg. Health Am."},{"key":"57867_CR2","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston, G. et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396, 413\u2013446 (2020).","journal-title":"Lancet"},{"key":"57867_CR3","doi-asserted-by":"publisher","first-page":"e2219672","DOI":"10.1001\/jamanetworkopen.2022.19672","volume":"5","author":"M Lee","year":"2022","unstructured":"Lee, M. et al. Variation in population attributable fraction of dementia associated with potentially modifiable risk factors by race and ethnicity in the US. JAMA Netw. Open 5, e2219672 (2022).","journal-title":"JAMA Netw. Open"},{"key":"57867_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2337\/dc14-1196","volume":"38","author":"G Erus","year":"2015","unstructured":"Erus, G. et al. Spatial patterns of structural brain changes in type 2 diabetic patients and their longitudinal progression with intensive control of blood glucose. Diabetes Care 38, 97\u2013104 (2015).","journal-title":"Diabetes Care"},{"key":"57867_CR5","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1093\/brain\/aww008","volume":"139","author":"M Habes","year":"2016","unstructured":"Habes, M. et al. White matter hyperintensities and imaging patterns of brain ageing in the general population. Brain 139, 1164\u20131179 (2016).","journal-title":"Brain"},{"key":"57867_CR6","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1093\/brain\/awp091","volume":"132","author":"C Davatzikos","year":"2009","unstructured":"Davatzikos, C. et al. Longitudinal progression of Alzheimer\u2019s-like patterns of atrophy in normal older adults: the SPARE-AD index. Brain 132, 2026\u20132035 (2009).","journal-title":"Brain"},{"key":"57867_CR7","doi-asserted-by":"publisher","unstructured":"Elbejjani, M. et al. Cigarette smoking and gray matter brain volumes in middle age adults: the CARDIA Brain MRI sub-study. Transl. Psychiatry 9, https:\/\/doi.org\/10.1038\/s41398-019-0401-1 (2019).","DOI":"10.1038\/s41398-019-0401-1"},{"key":"57867_CR8","doi-asserted-by":"publisher","first-page":"116450","DOI":"10.1016\/j.neuroimage.2019.116450","volume":"208","author":"R Pomponio","year":"2020","unstructured":"Pomponio, R. et al. Harmonization of large MRI datasets for the analysis of brain imaging patterns throughout the lifespan. Neuroimage 208, 116450 (2020).","journal-title":"Neuroimage"},{"key":"57867_CR9","first-page":"209","volume":"70","author":"JW Davis","year":"2011","unstructured":"Davis, J. W., Chung, R. & Juarez, D. T. Prevalence of comorbid conditions with aging among patients with diabetes and cardiovascular disease. Hawaii Med. J. 70, 209\u2013213 (2011).","journal-title":"Hawaii Med. J."},{"key":"57867_CR10","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1097\/HJH.0b013e32836184b5","volume":"31","author":"O Beauchet","year":"2013","unstructured":"Beauchet, O. et al. Blood pressure levels and brain volume reduction: a systematic review and meta-analysis. J. Hypertens. 31, 1502\u20131516 (2013).","journal-title":"J. Hypertens."},{"key":"57867_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/obr.12799","volume":"20","author":"MJ Herrmann","year":"2019","unstructured":"Herrmann, M. J. et al. Grey matter alterations in obesity: a meta-analysis of whole-brain studies. Obes. Rev. 20, 464\u2013471 (2019).","journal-title":"Obes. Rev."},{"key":"57867_CR12","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/1753-0407.12646","volume":"10","author":"F Fang","year":"2018","unstructured":"Fang, F. et al. Brain atrophy in middle-aged subjects with type 2 diabetes mellitus, with and without microvascular complications. J. Diab. 10, 625\u2013632 (2018).","journal-title":"J. Diab."},{"key":"57867_CR13","doi-asserted-by":"publisher","first-page":"e4260","DOI":"10.1210\/clinem\/dgab135","volume":"106","author":"F Morys","year":"2021","unstructured":"Morys, F., Dadar, M. & Dagher, A. Association between midlife obesity and its metabolic consequences, cerebrovascular disease, and cognitive decline. J. Clin. Endocrinol. Metab. 106, e4260\u2013e4274 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"57867_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.neurobiolaging.2021.02.002","volume":"102","author":"O Trofimova","year":"2021","unstructured":"Trofimova, O. et al. Brain tissue properties link cardio-vascular risk factors, mood and cognitive performance in the CoLaus|PsyCoLaus epidemiological cohort. Neurobiol. Aging 102, 50\u201363 (2021).","journal-title":"Neurobiol. Aging"},{"key":"57867_CR15","doi-asserted-by":"publisher","first-page":"e823","DOI":"10.1212\/WNL.0000000000006955","volume":"92","author":"C Moran","year":"2019","unstructured":"Moran, C. et al. Type 2 diabetes mellitus, brain atrophy, and cognitive decline. Neurology 92, e823\u2013e830 (2019).","journal-title":"Neurology"},{"key":"57867_CR16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3389\/fnagi.2017.00345","volume":"9","author":"BJ Neth","year":"2017","unstructured":"Neth, B. J. & Craft, S. Insulin resistance and Alzheimer\u2019s disease: bioenergetic linkages. Front. Aging Neurosci. 9, 345 (2017).","journal-title":"Front. Aging Neurosci."},{"key":"57867_CR17","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1212\/WNL.0b013e31826846de","volume":"79","author":"N Cherbuin","year":"2012","unstructured":"Cherbuin, N., Sachdev, P. & Anstey, K. J. Higher normal fasting plasma glucose is associated with hippocampal atrophy: The PATH Study. Neurology 79, 1019\u20131026 (2012).","journal-title":"Neurology"},{"key":"57867_CR18","doi-asserted-by":"publisher","first-page":"e60515","DOI":"10.1371\/journal.pone.0060515","volume":"8","author":"JH Lee","year":"2013","unstructured":"Lee, J. H. et al. Morphometric changes in lateral ventricles of patients with recent-onset type 2 diabetes mellitus. PLoS ONE 8, e60515 (2013).","journal-title":"PLoS ONE"},{"key":"57867_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2337\/db08-0586","volume":"58","author":"W Xu","year":"2009","unstructured":"Xu, W. et al. Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study. Diabetes 58, 71\u201377 (2009).","journal-title":"Diabetes"},{"key":"57867_CR20","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1161\/HYPERTENSIONAHA.121.17608","volume":"78","author":"X Shang","year":"2021","unstructured":"Shang, X. et al. The association of age at diagnosis of hypertension with brain structure and incident dementia in the UK Biobank. Hypertension 78, 1463\u20131474 (2021).","journal-title":"Hypertension"},{"key":"57867_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13195-021-00830-7","volume":"13","author":"CA Lane","year":"2021","unstructured":"Lane, C. A. et al. Investigating the relationship between BMI across adulthood and late life brain pathologies. Alzheimer\u2019s Res. Ther. 13, 91 (2021).","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"57867_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1212\/WNL.0000000000000550","volume":"83","author":"S Villeneuve","year":"2014","unstructured":"Villeneuve, S. et al. Vascular risk and Abeta interact to reduce cortical thickness in AD vulnerable brain regions. Neurology 83, 40\u201347 (2014).","journal-title":"Neurology"},{"key":"57867_CR23","doi-asserted-by":"publisher","first-page":"e207806","DOI":"10.1212\/WNL.0000000000207806","volume":"102","author":"H Jang","year":"2024","unstructured":"Jang, H. et al. Association of glycemic variability with imaging markers of vascular burden, beta-amyloid, brain atrophy, and cognitive impairment. Neurology 102, e207806 (2024).","journal-title":"Neurology"},{"key":"57867_CR24","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jalz.2014.04.521","volume":"11","author":"BS Ye","year":"2015","unstructured":"Ye, B. S. et al. Amyloid burden, cerebrovascular disease, brain atrophy, and cognition in cognitively impaired patients. Alzheimers Dement. 11, 494\u2013503.e3 (2015).","journal-title":"Alzheimers Dement."},{"key":"57867_CR25","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1212\/WNL.0000000000200551","volume":"99","author":"JS Rabin","year":"2022","unstructured":"Rabin, J. S. et al. Association of beta-amyloid and vascular risk on longitudinal patterns of brain atrophy. Neurology 99, e270\u2013e280 (2022).","journal-title":"Neurology"},{"key":"57867_CR26","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1212\/WNL.0b013e31826c1b9d","volume":"79","author":"RY Lo","year":"2012","unstructured":"Lo, R. Y. et al. Vascular burden and Alzheimer disease pathologic progression. Neurology 79, 1349\u20131355 (2012).","journal-title":"Neurology"},{"key":"57867_CR27","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1016\/j.neurobiolaging.2015.05.021","volume":"36","author":"TJ Hohman","year":"2015","unstructured":"Hohman, T. J. et al. Stroke risk interacts with Alzheimer\u2019s disease biomarkers on brain aging outcomes. Neurobiol. Aging 36, 2501\u20132508 (2015).","journal-title":"Neurobiol. Aging"},{"key":"57867_CR28","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/j.1532-5415.2005.53360.x","volume":"53","author":"AB Newman","year":"2005","unstructured":"Newman, A. B. et al. Dementia and Alzheimer\u2019s disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J. Am. Geriatr. Soc. 53, 1101\u20131107 (2005).","journal-title":"J. Am. Geriatr. Soc."},{"key":"57867_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-3-030-33330-0_4","volume":"1216","author":"M Noale","year":"2020","unstructured":"Noale, M., Limongi, F. & Maggi, S. Epidemiology of cardiovascular diseases in the elderly. Adv. Exp. Med Biol. 1216, 29\u201338 (2020).","journal-title":"Adv. Exp. Med Biol."},{"key":"57867_CR30","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s11886-012-0304-8","volume":"14","author":"H Muqtadar","year":"2012","unstructured":"Muqtadar, H., Testai, F. D. & Gorelick, P. B. The dementia of cardiac disease. Curr. Cardiol. Rep. 14, 732\u2013740 (2012).","journal-title":"Curr. Cardiol. Rep."},{"key":"57867_CR31","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1001\/jamaneurol.2021.0178","volume":"78","author":"IM Nasrallah","year":"2021","unstructured":"Nasrallah, I. M. et al. Association of intensive vs standard blood pressure control with magnetic resonance imaging biomarkers of Alzheimer disease: secondary analysis of the SPRINT MIND Randomized Trial. JAMA Neurol. 78, 568\u2013577 (2021).","journal-title":"JAMA Neurol."},{"key":"57867_CR32","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.neuroimage.2015.11.073","volume":"127","author":"J Doshi","year":"2016","unstructured":"Doshi, J. et al. MUSE: MUlti-atlas region Segmentation utilizing Ensembles of registration algorithms and parameters, and locally optimal atlas selection. Neuroimage 127, 186\u2013195 (2016).","journal-title":"Neuroimage"},{"key":"57867_CR33","doi-asserted-by":"publisher","unstructured":"Doshi, J. et al. DeepMRSeg: a convolutional deep neural network for anatomy and abnormality segmentation on MR images. Preprint at https:\/\/doi.org\/10.48550\/arXiv.1907.02110 (2019).","DOI":"10.48550\/arXiv.1907.02110"},{"key":"57867_CR34","doi-asserted-by":"publisher","first-page":"117248","DOI":"10.1016\/j.neuroimage.2020.117248","volume":"223","author":"D Srinivasan","year":"2020","unstructured":"Srinivasan, D. et al. A comparison of Freesurfer and multi-atlas MUSE for brain anatomy segmentation: Findings about size and age bias, and inter-scanner stability in multi-site aging studies. NeuroImage 223, 117248 (2020).","journal-title":"NeuroImage"},{"key":"57867_CR35","doi-asserted-by":"publisher","unstructured":"Govindarajan, S. T. et al. Machine learning reveals distinct neuroanatomical signatures of cardiovascular and metabolic diseases in cognitively unimpaired individual. GitHub via Zeonodo. https:\/\/doi.org\/10.5281\/zenodo.14872923 (2025).","DOI":"10.5281\/zenodo.14872923"},{"key":"57867_CR36","doi-asserted-by":"crossref","unstructured":"Cohen, J. Statistical Power Analysis for the Behavioral Sciences (Academic Press, 2013).","DOI":"10.4324\/9780203771587"},{"key":"57867_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/alz.12178","volume":"17","author":"M Habes","year":"2021","unstructured":"Habes, M. et al. The Brain Chart of Aging: machine-learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans. Alzheimers Dement. 17, 89\u2013102 (2021).","journal-title":"Alzheimers Dement."},{"key":"57867_CR38","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.21610","volume":"65","author":"LM Shaw","year":"2009","unstructured":"Shaw, L. M. et al. Cerebrospinal fluid biomarker signature in Alzheimer\u2019s disease neuroimaging initiative subjects. Ann. Neurol. 65, 403\u2013413 (2009).","journal-title":"Ann. Neurol."},{"key":"57867_CR39","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1001\/jamaneurol.2016.0194","volume":"73","author":"A Soldan","year":"2016","unstructured":"Soldan, A. et al. Hypothetical preclinical Alzheimer disease groups and longitudinal cognitive change. JAMA Neurol. 73, 698\u2013705 (2016).","journal-title":"JAMA Neurol."},{"key":"57867_CR40","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1093\/cercor\/bhr271","volume":"22","author":"M Ewers","year":"2012","unstructured":"Ewers, M. et al. CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects. Cereb. Cortex 22, 1993\u20132004 (2012).","journal-title":"Cereb. Cortex"},{"key":"57867_CR41","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","volume":"31","author":"CC Rowe","year":"2010","unstructured":"Rowe, C. C. et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol. Aging 31, 1275\u20131283 (2010).","journal-title":"Neurobiol. Aging"},{"key":"57867_CR42","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3389\/fnagi.2018.00408","volume":"10","author":"RJ Kamil","year":"2018","unstructured":"Kamil, R. J. et al. Vestibular function and beta-amyloid deposition in the Baltimore longitudinal study of aging. Front. Aging Neurosci. 10, 408 (2018).","journal-title":"Front. Aging Neurosci."},{"key":"57867_CR43","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13195-021-00819-2","volume":"13","author":"I Lopes Alves","year":"2021","unstructured":"Lopes Alves, I. et al. Strategies to reduce sample sizes in Alzheimer\u2019s disease primary and secondary prevention trials using longitudinal amyloid PET imaging. Alzheimer\u2019s Res. Ther. 13, 82 (2021).","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"57867_CR44","doi-asserted-by":"publisher","first-page":"378","DOI":"10.2967\/jnumed.111.090340","volume":"53","author":"AD Joshi","year":"2012","unstructured":"Joshi, A. D. et al. Performance characteristics of amyloid PET with florbetapir F 18 in patients with Alzheimer\u2019s disease and cognitively normal subjects. J. Nucl. Med. 53, 378\u2013384 (2012).","journal-title":"J. Nucl. Med."},{"key":"57867_CR45","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1016\/j.jalz.2012.10.007","volume":"9","author":"KA Johnson","year":"2013","unstructured":"Johnson, K. A. et al. Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer\u2019s disease dementia, mild cognitive impairment, and normal aging. Alzheimers Dement. 9, S72\u2013S83 (2013).","journal-title":"Alzheimers Dement."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57867-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57867-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57867-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:28:37Z","timestamp":1742430517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57867-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["57867"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-57867-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]},"assertion":[{"value":"9 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.L.S.B. has received investigator-initiated research funding from the NIH, the Alzheimer\u2019s Association, the Foundation at Barnes-Jewish Hospital, Siemens Healthineers, and Avid Radiopharmaceuticals (a wholly owned subsidiary of Eli Lilly and Company). She participates as a site investigator in clinical trials sponsored by Eli Lilly and Company, Biogen, Eisai, Jaansen, and Roche. She has served as a paid and unpaid consultant to Eisai, Siemens, Biogen, Janssen, and Bristol-Myers Squibb. J.C.M. has served as a paid consultant to the Barcelona Brain Research Center and the Native Alzheimer Disease-related Resource Center in Minority Aging Research. He also received payments for presentations at the AAIM meeting, Longer Life Foundation, and the International Brain Health Symposium. JCM has received travel support to attend meetings including AAIM, DIAN, AD\/PD, ATRI\/ADNI, ADRC, ADC, the International Conference on Health Aging & Biomarkers, and the International Brain Health Symposium. He has served on the advisory board for the Cure Alzheimer\u2019s Fund and LEADS at Indiana University. S.M.R. is an NIA IRP employee and has served on the advisory board of Dementia Platforms, UK, the Canadian Consortium on Neurodegeneration in Aging, and the Adult Aging Brain Connectome. She has received travel support from the McKnight Foundation to attend an annual meeting. D.A.W. has served as a paid consultant to Beckman Coulter and Eli Lilly. He also received grants from the NIH and Biogen paid to his institution and received travel support from the Alzheimer\u2019s Association. He has served on the DSMB of studies by Functional Neuromodulation and GSK. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2724"}}